CS Paper Radar

Can Unsupervised Methods Outperform Supervised Deep Learning When Ground Truth Is Sparse? A Case Study of Bronchovascular Bundle Segmentation in Low-Dose CT

Anna Mrukwa, Marek Socha, Aleksandra Suwalska, Agata Durawa, Malgorzata Jelitto, Katarzyna Dziadziuszko, Edyta Szurowska, Pawel Bozek, Michal Marczyk, Witold Rzyman, Rafal Dziadziuszko, Joanna Polanska

cs.CV ·submitted 2026-08-17 17:38 UTC · v1

Abstract

Background Lung cancer remains the deadliest cancer worldwide because it is often diagnosed too late. Effective treatment depends on detection at an early screening stage. However, the growing number of patients and the limited number of radiologists lead to prolonged diagnostic waiting times. In very early stage lung cancer, nodule visibility is further reduced by adjacent blood vessels and airway walls, because nodules are often connected to or supplied by these structures. Task-specific analysis of the bronchovascular bundle is therefore important for efficient nodule detection, and its removal can increase the diagnostic potential of lung cancer screening. Materials and Methods To assess the efficacy of the proposed method, we used series from widely utilized LDCT datasets, including the Duke Lung Cancer Screening (DLCS) dataset and the Pilot Pomeranian Lung Cancer Screening Program. The proposed bronchovascular bundle segmentation pipeline, RONALD, operates on computed tomography images and returns binary masks of vessels and bronchi located in the lung parenchyma. The method includes a preprocessing stage with lung, lobe, and mediastinum segmentation, followed by separate vessel and bronchial tree segmentation. Results The proposed pipeline segmented the bronchovascular bundle in low-dose computed tomography scans while improving nodule retention compared with other segmentation methods: from 93.98% and 90.36% to 100% in DLCS, and from 83.16% and 62.36% to 99.92% in the Pomeranian dataset. Conclusion The resulting segmentations can improve lung nodule detection in the very early stages of lung cancer.

Comment
17 pages, 4 figures. Part of this research was submitted to the international conference European Molecular Imaging Meeting 2026

Closest papers

Nearest neighbours by meaning across the whole index.

NoduleFlow: Automatic 3D Lung Nodule Detection and Segmentation

cs.CV ·2026-10-12 ·Giulia Romoli, Filippo Ruffini, Francesco Di Feola, Valerio Guarrasi, Matteo Tortora +1 more
similarity 0.75
Abstract

Low dose Computed Tomography (CT) is the standard imaging modality for lung cancer screening. On CT scans, lung cancer typically manifests as pulmonary nodules, whose manual identification is time-consuming and prone to observer variability, image quality limitations, and suboptimal reading conditions. Moreover, subtle temporal changes are often difficult to quantify reliably in CT scans from the same patient across follow-up examinations. Deep learning-based approaches for the automatic detection and segmentation of lung nodules have demonstrated improved accuracy and efficiency. However, most existing approaches provide only coarse region-of-interest localisation, rely on prior lesion annotations or human supervision, or treat detection and segmentation as separate tasks. In this work, we present NoduleFlow, a framework for lung nodule detection, classification, and segmentation directly from series of CT volumes. Our proposal consists of four interconnected modules and operates in an automated manner at inference time, without requiring prior lesion annotations, manual initialisation, or region-of-interest pre-selection. We further investigate whether nodule localization benefits from the propagation of candidate regions across follow-up scans through inter-scan registration fields, as opposed to conventional independent per-scan analysis. The generalisability of the framework is systematically evaluated across four independent datasets. The results underscore the potential of automated pipelines for lung nodule analysis in screening and diagnostic settings.

0.14

LUCQUE: A lung cancer screening dataset from Québec for reliable AI evaluation

cs.DB cs.AI ·2026-11-09 ·Johanna Topalis, Yannick Lemaréchal, Gabriel Couture, Hanife Ersay, Loran Nas +5 more
similarity 0.74
Abstract

BACKGROUND: AI-based tools are expected to play a key role in lung cancer screening (LCS). The evaluation of these tools often relied on private datasets or fragmented public datasets with inconsistent availability of clinical data and expert nodule annotations. This has hindered reproducibility, comparability, and independent assessment of AI tools. To address these gaps, we present LUCQUE, a novel, large, comprehensively annotated dataset derived from LDCT lung cancer screening in Québec, which is accessible for reliable AI evaluation. METHODS: LUCQUE was curated and is hosted on PARADIM, a digital infrastructure supporting DICOM data de-identification, annotation, long-term storage and analysis. LDCT scans and clinical information were combined to a curated collection and complemented by voxel-level, expert-derived pulmonary nodule and cyst segmentations, and Lung-RADS-based lesion characteristics. Key dataset characteristics and statistics were reported, including participant demographics, imaging parameters, radiological findings, and segmented lesion characteristics. Dataset analyses were conducted according to PARADIM's model-to-data approach, in which user code is executed on the platform such that data remains on premise. RESULTS: LUCQUE currently comprises 1,678 LDCT baseline studies from 1,678 participants. Most studies were classified as Lung-RADS 2. A total of 1,776 pulmonary nodules and 60 cysts were annotated, with a median (interquartile range) volume of $89\,(56,\,159)\,\mathrm{mm}^3$ and $1,384\,(589,\,3793)\,\mathrm{mm}^3$ respectively. CONCLUSIONS: Compared to publicly available LCS datasets, LUCQUE currently represents the largest accessible annotated real-world LCS dataset. Access to LUCQUE is provided via a model-to-data approach, enabling privacy-preserving, reproducible, and independent real-world evaluation of AI tools in LCS.

0.21

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

cs.CV cs.AI ·2026-08-16 ·Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
benchmark similarity 0.72
Abstract · 8 pages

Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination. Although deep learning has shown considerable potential in computational pathology, comprehensive benchmarks that integrate tissue classification and region segmentation within a unified analytical framework remain limited. This study presents a two-stage deep learning framework for multi-class tissue classification and pixel-level histopathological region segmentation, accompanied by a systematic comparison of state-of-the-art architectures at each stage. For tissue classification, six models, a custom convolutional neural network, VGG16, DenseNet, MobileNetV3, a custom Vision Transformer, and YOLO11, are evaluated on a combined dataset of 39,000 images derived from LC25000 and LungHist700. The models distinguish between adenocarcinoma, squamous cell carcinoma, and normal lung tissue. YOLO11 achieves the best classification performance, with an accuracy of 98.38%, a five-fold cross-validation accuracy of 98.21 +/- 0.35%, and a macro F1-score of 0.98. For region segmentation, U-Net, ResNet-encoder U-Net, DeepLabV3+, and YOLO11-seg are evaluated using the GlaS gland segmentation benchmark. DeepLabV3+ obtains the highest Intersection over Union of 0.80 and a Dice score of 0.89, while YOLO11-seg achieves a comparable Intersection over Union of 0.79 using approximately 14x fewer parameters. The best-performing classification and segmentation models are subsequently integrated into an end-to-end framework, providing an accurate, computationally efficient, and reproducible baseline for automated histopathological image analysis.

0.40

Annotating anatomy and pathology in the National Lung Screening Trial computed tomography images

eess.IV ·2026-09-09 ·Deepa Krishnaswamy, Vamsi Thiriveedhi, Suraj Pai, David Clunie, Igor Octaviano +4 more
similarity 0.71
Abstract

Large-scale public medical imaging datasets contribute critically to translational research. When accompanied by rich clinical and multi-omics data, they can stimulate exploratory research and enable secondary analyses. Expert annotations of such imaging collections can support the development of new image analysis tools. Continuous enrichment of images with image-derived data makes them more usable for researchers without expertise in image analysis or access to large-scale computational resources. The National Lung Screening Trial (NLST) released a rich longitudinal dataset that includes Computed Tomography (CT) images for over 26,000 patients. We introduce three Digital Imaging and Communications in Medicine (DICOM) formatted datasets, complementing NLST CT images, shared as analysis results in the National Cancer Institute Imaging Data Commons (IDC). Two of those (IDC NLSTSeg and IDC NLSTSybil) contain DICOM-harmonized annotations and extracted measurements (for 581 and 601 NLST patients, respectively) shared earlier using research formats (Sybil and NLSTseg). The third one (TotalSegmentator-CT-Segmentations) contains volumetric segmentations generated using TotalSegmentator and radiomics features for each segment for 26,194 NLST patients.

0.18

From Slices to Volumes: Comparing 2D, 2.5D, and 3D Residual Networks for Pulmonary Nodule Malignancy-Risk Classification

cs.LG cs.CV ·2026-10-25 ·Bahodir Nazarov, Zineb Gharib, Fatima Zazoul
code/data similarity 0.70
Abstract

Purpose: To compare 2D, 2.5D, and 3D residual networks for pulmonary nodule malignancy-risk classification and evaluate momentum-contrast pretraining, mild augmentation, and exclusion of indeterminate ratings. Methods: A retrospectively prepared LIDC-IDRI cohort contained 2,654 nodules labeled benign, indeterminate, or malignant using median radiologist ratings. Patient-disjoint splits comprised 1,876 training, 382 validation, and 396 test nodules. Representations included one axial slice, five neighboring slices, and a local CT volume. Each track evaluated a randomly initialized baseline, momentum-contrast pretraining followed by fine-tuning, and supervised training with mild augmentation. Checkpoints were selected by validation Macro-F1. The 2D experiments used three seeds; 2.5D and 3D results were single-run estimates. A separate binary experiment excluded indeterminate nodules. Results: Augmented models achieved test Macro-F1 values of $0.6134\pm0.0075$ for 2D, $0.6537$ for 2.5D, and $0.5403$ for 3D; the 2D uncertainty denotes population standard deviation across seeds. Corresponding accuracies were $0.6128$, $0.6869$, and $0.5455$. Augmentation improved Macro-F1 within every track, whereas the tested pretraining recipes reduced it. Binary Macro-F1 values were $0.8227$, $0.8664$, and $0.7554$, respectively. Conclusion: Augmented 2.5D achieved the highest observed performance. Differences in preprocessing, optimization, capacity, and replication limit attribution to dimensionality. Labels reflect radiologist-assessed malignancy risk rather than pathology-confirmed cancer. Code and experimental results are available at https://github.com/CT-DeepLearning-Team/CT-2D-2.5D-3D-DeepLearning.

0.18

GRIPNet: Gaussian Radial Intensity Prior Guided Architecture for Pulmonary Nodule Detection in CT

cs.CV cs.AI ·2026-09-10 ·Haojie Yang, Ran Su
similarity 0.69
Abstract

Lung cancer causes more deaths than any other malignancy, and low-dose CT screening is the main pathway to early diagnosis. That pathway hinges on the smallest lesions, yet nodules below six millimeters remain hard to detect, because most methods treat a nodule as a generic object and ignore the imaging physics behind its appearance. We show that this appearance is highly regular. Intensity peaks at the geometric center of a nodule and decays radially in a Gaussian pattern, and a fit to 18,218 annotated lesions from three public benchmarks yields a mean radial coefficient of determination above 0.86 in every dataset and size stratum. A square convolution samples both axes uniformly and is mismatched to this radial signal, most severely for small nodules. Guided by this evidence, we propose GRIPNet (Gaussian Radial Intensity Prior Network), a detector in which every module maps to a measurable property of the intensity distribution. Pinwheel convolutions decompose radial gradients, a dual-frequency module separates boundary detail from structural context, dilated masked attention matches the decay extent, and an adaptive loss reweights samples by conspicuity. GRIPNet raises mAP@0.5 to 95.3, 91.6 and 97.9 percent on KanserSet, LUNA16 and Lung-PET-CT-Dx while sharpening high-IoU localization at real-time speed.

0.12

Artificial Intelligence Algorithms for the Detection of Pathologies Related to Lung Cancer through Image Analysis using Convolutional Neural Networks and Data Augmentation: a systematic mapping of the literature

cs.LG cs.CL ·2026-09-09 ·Pablo Ramirez Amador
similarity 0.68
Abstract

Lung cancer is one of the leading causes of death worldwide, and its early diagnosis is crucial to improving patients prognosis and quality of life. However, the process of interpreting medical images for the detection of lung cancer is complex and requires trained experts. In this context, artificial intelligence (AI) and deep learning (DL) emerge as potential tools to automate and optimize image analysis. The objective of this work is to review the most recent and relevant applications of AI and DL in the field of radiology for the detection of lung cancer. To this end, an exhaustive search was carried out in scientific databases such as PubMed,IEEEXPLORE, Scopus and Web of Science, and 96 articles published from 2015 to the present addressing the use of AI and DL in biomedical engineering were selected. Emphasis is placed on the use of convolutional neural networks (CNN) with transfer learning and Data Augmentation as promising techniques to improve the accuracy and efficiency of the image interpretation process. The results show that the use of AI and DL can offer an effective alternative for the early diagnosis of lung cancer, with high sensitivity and specificity. However, current limitations and challenges that must be addressed to guarantee its responsible and safe application in clinical practice are also identified, such as the lack of standardized data, the ex plainability of the models, patient privacy, and the ethical and social implications. It is concluded that the use of AI and DL can have a positive impact on the care of patients with lung cancer, but further research and regulation are required to ensure its quality and reliability.

0.15

Energy Efficient Lung Tumor Segmentation with a modified CBAM ENet Skip Model

cs.CV cs.AIcs.LG ·2026-10-24 ·Sharan Thummagunti, Aayushi Padia, Abhiram Koppuravuri, Prabhu Prasad B M, G N Girish
code/data similarity 0.66
Abstract

Lung tumor segmentation plays a vital role in early detection and treatment planning of lung cancer. Although state-of-the-art deep learning models achieve high dice score coefficients (DSC), each forward pass requires computing large amounts of floating point operations, making them computationally expensive, requiring GPU acceleration, and having slow inference speed, limiting real-world clinical deployment. We propose a lightweight, energy-efficient model that leverages the ENet architecture for its real-time inference capability and low computational cost, enhanced with UNet-style skip connections between encoder and decoder stages for feature reuse and the lightweight Convolutional Block Attention Module (CBAM) for improved feature representation. The model is trained on publicly available data from The Cancer Imaging Archive (TCIA) via the Medical Segmentation Decathlon Challenge (MSD) and evaluated on the Lung Image Database Consortium and Image Database Resource Initiative (LIDC-IDRI) dataset. Our model achieves a DSC of 0.90812 (threshold of 0.5) with its compact architecture of 430,052 parameters and 0.549 Giga Multiply-Accumulate operations (GMAC), making it up to 10 times faster, requires 79 times less GMAC than UNet, and has 22 times fewer parameters than SegNet. These characteristics make it well-suited for deployment in clinical settings where computational resources are limited and decrease the cost of utilizing such a system. Additionally, the explainable AI technique of Grad-CAM is used to provide visual interpretability of the model's predictions and to identify regions where segmentation performance requires improvement.

0.36